Literature DB >> 8504662

Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine.

P A Lee1, J R Matson, R W Pryor, L B Hinshaw.   

Abstract

OBJECTIVES: The goals of this study were: a) to evaluate the efficacy of controlled, continuous arteriovenous hemofiltration in improving morbidity and mortality rates in an immature swine model of Staphylococcus aureus-induced septicemia; b) to determine if ultrafiltrate from septic animals contained mediators that produce pathophysiologic changes observed in untreated S. aureus septic pigs.
DESIGN: Prospective, randomized, controlled study with age-matched controls.
SETTING: U.S. Department of Agriculture-licensed biomedical research facility.
SUBJECTS: Sixty-five weaned Poland-China swine (4 to 6 wks of age; 5 to 10 kg).
INTERVENTIONS: Part 1: Animals received a lethal dose of live S. aureus (8 x 10(9) colony-forming units/kg) over 1 hr. The three treatment groups included: hemofiltration group 1 (eight filtered, eight nonfiltered animals), plasma filtration fraction = 5.5%; hemofiltration group 2 (six filtered, six nonfiltered animals), filtration fraction = 16.6%; and hemofiltration group 3 (six filtered, six nonfiltered animals), filtration fraction = 33.4%. A control, nonseptic group of animals (n = 4) was filtered to obtain "clean" ultrafiltrate (hemofiltration group 4). Part 2: Sterile ultrafiltrate concentrate batches obtained from each group of filtered, septic animals were concentrated and infused into healthy, nonseptic pigs (reinfusion groups 1 through 3).
MEASUREMENTS AND MAIN RESULTS: Physiologic, biochemical, and hematologic variables were measured in all animals every 1 to 3 hrs. Overall length of survival was also recorded. In hemofiltration groups 1 through 3, filtered animals survived significantly longer than matched, nonfiltered (sham-filtered) animals. Increments in survival time increased directly with filtration fraction. Ultrafiltrate concentrate from septic pigs produced death (LD41) and disease similar to those rates observed in untreated S. aureus-septic pigs. Infusion of clean ultrafiltrate concentrate produced no response.
CONCLUSIONS: Continuous arteriovenous hemofiltration significantly improved survival rates in swine with S. aureus-induced sepsis. Resultant ultrafiltrate concentrate contained mediators responsible for some pathophysiologic responses observed in this animal model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504662     DOI: 10.1097/00003246-199306000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs.

Authors:  E F Yekebas; H Treede; W T Knoefel; C Bloechle; E Fink; J R Izbicki
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

2.  Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis.

Authors:  J N Hoffmann; W H Hartl; R Deppisch; E Faist; M Jochum; D Inthorn
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

3.  Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome.

Authors:  Lu-Yi Liu; Yong-Jian Zhu; Xiao-Li Li; Ya-Feng Liang; Zuo-Peng Liang; Yong-Hong Xia
Journal:  World J Emerg Med       Date:  2012

Review 4.  Clinical review: blood purification for sepsis.

Authors:  Thomas Rimmelé; John A Kellum
Journal:  Crit Care       Date:  2011-02-16       Impact factor: 9.097

5.  High-volume hemofiltration in septic shock.

Authors:  Peter Rogiers
Journal:  Crit Care       Date:  2005-06-02       Impact factor: 9.097

6.  Hemofiltration in sepsis: where do we go from here?

Authors:  J A Kellum; R Bellomo
Journal:  Crit Care       Date:  2000-02-16       Impact factor: 9.097

Review 7.  High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis.

Authors:  Edward Clark; Amber O Molnar; Olivier Joannes-Boyau; Patrick M Honoré; Lindsey Sikora; Sean M Bagshaw
Journal:  Crit Care       Date:  2014-01-08       Impact factor: 9.097

Review 8.  Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.

Authors:  Patrick M Honoré; James R Matson
Journal:  Crit Care       Date:  2002-09-04       Impact factor: 9.097

Review 9.  Clinical review: extracorporeal blood purification in severe sepsis.

Authors:  Ramesh Venkataraman; Sanjay Subramanian; John A Kellum
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

10.  Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats.

Authors:  John A Kellum; Michael K Dishart
Journal:  Crit Care       Date:  2002-06-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.